Necrotizing fasciitis screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Necrotizing fasciitis}} | {{Necrotizing fasciitis}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}}; {{YK}} | ||
{{ | |||
==Overview== | ==Overview== | ||
| Line 16: | Line 14: | ||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
Revision as of 02:55, 18 September 2016
|
Necrotizing fasciitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Necrotizing fasciitis screening On the Web |
|
American Roentgen Ray Society Images of Necrotizing fasciitis screening |
|
Risk calculators and risk factors for Necrotizing fasciitis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: ; Yamuna Kondapally, M.B.B.S[2]
Overview
According to the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for necrotizing fasciitis.
Screening
According to the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for necrotizing fasciitis.